Is there an urban-rural-gradient in patients with urinary incontinence?

nork Wille, Sebastian, Katarzyna, Kawa, Ahrens, Ulrike, Eminaga, Okyaz, Engelmann, Udo, Jenny, Paas
Argitaratua 2014

CMDX©-based single source information system for simplified quality management and clinical research in prostate cancer

nork Eminaga, Okyaz, Abbas, Mahmoud, Hinkelammert, Reemt, Titze, Ulf, Bettendorf, Olaf, Eltze, Elke, Özgür, Enver, Semjonow, Axel
Argitaratua 2012

Clinical map document based on XML (cMDX): document architecture with mapping feature for reporting and analysing prostate cancer in radical prostatectomy specimens

nork Bettendorf Olaf, Koepke Thomas, Abbas Mahmoud, Neumann Joerg, Semjonow Axel, Hinkelammert Reemt, Eminaga Okyaz, Eltze Elke, Dugas Martin
Argitaratua 2010-11-01

Clinical map document based on XML (cMDX): document architecture with mapping feature for reporting and analysing prostate cancer in radical prostatectomy specimens

nork Eminaga, Okyaz, Hinkelammert, Reemt, Semjonow, Axel, Neumann, Joerg, Abbas, Mahmoud, Koepke, Thomas, Bettendorf, Olaf, Eltze, Elke, Dugas, Martin
Argitaratua 2010

A prognostic score for overall survival in patients treated with abiraterone in the pre- and post-chemotherapy setting

nork Boegemann, Martin, Schlack, Katrin, Früchtenicht, Lena, Steinestel, Julie, Schrader, Andres Jan, Wennmann, Yvonne, Krabbe, Laura-Maria, Eminaga, Okyaz
Argitaratua izan da Oncotarget (2019)

Catheterless Long-Term Ambulatory Urodynamic Measurement Using a Novel Three-Device System

nork Wille, Sebastian, Schumacher, Pauline, Paas, Jenny, Tenholte, Dirk, Eminaga, Okyaz, Müller, Ute, Muthen, Noemi, Mehner, Jan, Cornely, Oliver, Engelmann, Udo
Argitaratua 2014

Dynamic changes of alkaline phosphatase are strongly associated with PSA-decline and predict best clinical benefit earlier than PSA-changes under therapy with abiraterone acetate i...

nork Mikah, Phillip, Krabbe, Laura-Maria, Eminaga, Okyaz, Herrmann, Edwin, Papavassilis, Philipp, Hinkelammert, Reemt, Semjonow, Axel, Schrader, Andres-Jan, Boegemann, Martin
Argitaratua izan da BMC Cancer (2016)

Novel lincRNA SLINKY is a prognostic biomarker in kidney cancer

nork Gong, Xue, Siprashvili, Zurab, Eminaga, Okyaz, Shen, Zhewei, Sato, Yusuke, Kume, Haruki, Homma, Yukio, Ogawa, Seishi, Khavari, Paul A., Pollack, Jonathan R., Brooks, James D.
Argitaratua izan da Oncotarget (2017)

Genomic analysis of benign prostatic hyperplasia implicates cellular relandscaping in disease pathogenesis

nork Middleton, Lance W., Shen, Zhewei, Varma, Sushama, Pollack, Anna S., Gong, Xue, Zhu, Shirley, Zhu, Chunfang, Foley, Joseph W., Vennam, Sujay, Sweeney, Robert T., Tu, Karen, Biscocho, Jewison, Eminaga, Okyaz, Nolley, Rosalie, Tibshirani, Robert, Brooks, James D., West, Robert B., Pollack, Jonathan R.
Argitaratua izan da JCI Insight (2019)

MUC1 Expression by Immunohistochemistry Is Associated with Adverse Pathologic Features in Prostate Cancer: A Multi-Institutional Study

nork Eminaga, Okyaz, Wei, Wei, Hawley, Sarah J., Auman, Heidi, Newcomb, Lisa F., Simko, Jeff, Hurtado-Coll, Antonio, Troyer, Dean A., Carroll, Peter R., Gleave, Martin E., Lin, Daniel W., Nelson, Peter S., Thompson, Ian M., True, Lawrence D., McKenney, Jesse K., Feng, Ziding, Fazli, Ladan, Brooks, James D.
Argitaratua izan da PLoS One (2016)